IngentaConnect Induction of melanoma in TPras transgenic mice

Authors: Powell M.B.; Gause P.R.; Hyman P.; Gregus J.; Lluria-Prevatt M.; Nagle R.; Bowden G.T.

Source: Carcinogenesis, Volume 20, Number 9, September 1999 , pp. 1747-1753(7)

Abstract:

In order to study the oncogenesis of melanocytes, transgenic mouse lines were established that express a mutated human Ha-ras (TPras) gene in pigment producing cells. The ras transgenic mice exhibit an altered phenotype, including melanocytic hyperplasia and a muted agouti coat, indicative of hyperproliferative melanocytes. These mice and their wild-type littermates have been subjected to a variety of carcinogenesis protocols, including 7,12-dimethylbenz-[a]anthracene (DMBA), 12-O-tetradecanoylphorbol-13-acetate (TPA) and UV radiation exposure. Topical DMBA treatment of TPras mice resulted in a high incidence of melanomas. Metastatic lesions were observed in skin, lungs and lymph nodes. TPA treatment of TPras mice induced a small number of papillomas but no nevi or melanomas. UV light exposures induced papillomas in negative littermate and melanomas in some albino TPras mice. These results show that melanocytes expressing an activated Ha-ras in the TPras transgenic mice are susceptible to induction of melanoma by DMBA.

Document Type: Original article

Affiliations: Arizona Cancer Center, University of Arizona, 1515 North Campbell Avenue, PO Box 245042, Tucson, AZ 85724-5024, USA:

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$40.19 plus tax Refund Policy